Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

February 29, 2016

Conditions
Lung CancerSarcoidosisInterstitial Pneumonia
Interventions
DEVICE

Flexible bronchoscopy in moderate sedation

Flexible bronchoscopy for diagnosis of lung cancer, sarcoidosis or interstitial pneumonia in moderate sedation with propofol;

DEVICE

Oxygen saturation

Continuous measurement of oxygen saturation;

DEVICE

Blood pressure

Measurement of non-invasive blood pressure every 3 minutes

DEVICE

Propofol dosage

Report of dose adjustments und cumulative propofol dosage;

DEVICE

Recovery time after bronchoscopy

Recovery time after bronchoscopy from removal of bronchoscope to eye opening/answer to verbal stimuli (whatever comes first)

Trial Locations (1)

8091

University Hospital Zurich, Zurich

All Listed Sponsors
collaborator

B. Braun Melsungen AG

INDUSTRY

lead

Daniel Franzen

OTHER

NCT02246023 - Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy | Biotech Hunter | Biotech Hunter